Amifampridine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11640 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 84 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | glaucoma | KG + DL |
| 2 | acute intermittent porphyria | KG + DL |
| 3 | esophageal varices with bleeding | KG + DL |
| 4 | esophageal varices without bleeding | KG + DL |
| 5 | porphyria | KG + DL |
| 6 | primary immunodeficiency syndrome due to p14 deficiency | KG + DL |
| 7 | paraneoplastic limbic encephalitis | KG + DL |
| 8 | paraneoplastic polyneuropathy | KG + DL |
| 9 | varicose disease | KG + DL |
| 10 | paraneoplastic cerebellar degeneration | KG + DL |
| 11 | Steel syndrome | KG + DL |
| 12 | Barth syndrome | KG + DL |
| 13 | autosomal dominant keratitis | KG + DL |
| 14 | erythropoietic uroporphyria associated with myeloid malignancy | KG + DL |
| 15 | hereditary photodermatosis | KG + DL |
| 16 | pancreatitis | KG + DL |
| 17 | autosomal dominant Alport syndrome | KG + DL |
| 18 | monilethrix | KG + DL |
| 19 | severe congenital neutropenia | KG + DL |
| 20 | hypophosphatasia | KG + DL |
| 21 | contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A | KG + DL |
| 22 | retinoschisis, autosomal dominant | KG + DL |
| 23 | hand-foot-genital syndrome | KG + DL |
| 24 | alcoholic cardiomyopathy | KG + DL |
| 25 | autosomal dominant omodysplasia | KG + DL |
| 26 | autosomal dominant brachyolmia | KG + DL |
| 27 | Flynn-Aird syndrome | KG + DL |
| 28 | LADD syndrome | KG + DL |
| 29 | autosomal dominant Kenny-Caffey syndrome | KG + DL |
| 30 | Pelger-Huet anomaly | KG + DL |
| 31 | tremor-nystagmus-duodenal ulcer syndrome | KG + DL |
| 32 | congenital stationary night blindness autosomal dominant | KG + DL |
| 33 | glaucoma 3, primary infantile, B | KG + DL |
| 34 | autosomal dominant Aarskog syndrome | KG + DL |
| 35 | generalized basal epidermolysis bullosa simplex with skin atrophy, scarring and hair loss | KG + DL |
| 36 | benign paroxysmal tonic upgaze of childhood with ataxia | KG + DL |
| 37 | Pilarowski-Bjornsson syndrome | KG + DL |
| 38 | primary orthostatic tremor | KG + DL |
| 39 | arthrogryposis, distal, | KG + DL |
| 40 | autosomal dominant Ehlers-Danlos syndrome, vascular type | KG + DL |
| 41 | psychogenic movement disorders | KG + DL |
| 42 | constitutional megaloblastic anemia due to vitamin B12 metabolism disorder | KG + DL |
| 43 | autosomal dominant vibratory urticaria | KG + DL |
| 44 | autosomal dominant complex spastic paraplegia | KG + DL |
| 45 | autosomal dominant pure spastic paraplegia | KG + DL |
| 46 | autosomal dominant Opitz G/BBB syndrome | KG + DL |
| 47 | tarsal-carpal coalition syndrome | KG + DL |
| 48 | autosomal dominant spastic ataxia | KG + DL |
| 49 | chronic tic disorder | KG + DL |
| 50 | autosomal dominant rhegmatogenous retinal detachment | KG + DL |
(Showing top 50 of 84 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.